[1] MU F, DUAN J L, WEN A D, et al. Application of metabonomics in the study of efficacy material base and mechanism of traditional Chinese medicine in the treatment of coronary heart disease[J]. Chin J New Drugs(中国新药杂志), 2015, 24(19):2197-2202.
[2] SONG H P, YANG H, GAO W, et al. Advances in key techniques for the discovery of active ingredients in traditional Chinese medicine[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2016, 18(7):1093-1098.
[3] LUO G A, XIE Y Y, WANG Y M, et al. Research on the modernization of precision medicine and traditional Chinese medicine--five on the establishment of new medicine[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2017, 19(1):19-29.
[4] LUO G A, WANG Y M. The research method and theory of the effective part of TCM compound prescription[J]. Chin Tradit Pat Med(中成药), 1997, 19(8):44-45.
[5] HOOD L, HEATH J R, PHELPS M E, et al. Systems biology and new technologies enable predictive and preventative medicine[J]. Science, 2004, 306(5696):640-643.
[6] LUO G A, LIANG Q L, ZHANG R L, et al. Chemical composition and traditional Chinese medicine--it also analyzes the material basis of kailing compound[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2006, 8(1):6-15.
[7] LUO G A, LIANG Q L, LIU Q F, et al. Integrated holistic systems biology of chemical composition--a holistic methodology for the study of compatibility and mechanism of action of TCM compounds[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2007, 9(1):10-15.
[8] FU J H, FU Y, LIU J X. Conception of the "component Chinese medicine" hypothesis[J]. Chin J Inf Tradit Chin Med(中国中医药信息杂志), 2006, 13(1):52-54.
[9] LI A X. The proposal of "pharmacodynamic property hypothesis" of traditional Chinese medicine[J]. Tianjin Pharm(天津药学), 2007, 19(2):41-44.
[10] WANG X J. The formation and development of Chinese medicine serum pharmacochemistry[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2010, 12(4):632-633.[11] XU F, YANG D H, SHANG M Y, et al. "Obvious form", "superposition effect" and "toxic dispersion effect" of medicinal materials--reflections on metabolism of traditional Chinese medicine[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2014, 26(4):688-703.
[12] ZE L M G, ZHANG X F, SU D N, et al. Application status of serum pharmacochemistry in traditional Chinese medicine[J]. J China Pharm(中国药房), 2017, 28(7):978-981.
[13] WANG X J. Chinese Medicine Serum Pharmacochemistry(中药血清药物化学)[M]. Beijing: Science Press, 2010: 42.
[14] MA F X, XUE P F, WANG Y Y, et al. Research progress of serum pharmacochemistry of traditional Chinese medicine[J]. China J Chin Mater Med(中国中药杂志), 2017, 42(7):1265-1270.
[15] AN R, LI Y, LI M, et al. Plasma pharmacochemistry combined with pharmacokinetics and pattern recognition analysis to screen potentially bioactive components from Daming capsule using ultra high performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry[J]. J Sep Sci, 2015, 38(9):1507-1514.
[16] LI X, ZHANG A, SUN H, et al. Rapid discovery of absorbed constituents and metabolites in rat plasma after the oral administration of Zi Shen Wan using high-throughput UHPLC-MS with a multivariate analysis approach[J]. J Sep Sci, 2016, 39(24):4700-4711.
[17] HAN Y, WU F, ZHANG A, et al. Characterization of multiple constituents in rat plasma after oral administration of Shengmai San using ultra-performance liquid chromatography coupled with electrospray ionization/quadrupole-time-of-flight high-definition mass spectrometry[J]. Anal Methods, 2015, 7(3):830-837.
[18] LIU C, ZHANG A, HAN Y, et al. Ultra-high performance liquid chromatography coupled with time-of-flight mass spectrometry screening and analysis of potential bioactive compounds from traditional chinese medicine Kai-Xin-San, using a multivariate data processing approach and the MetaboLynx tool[J]. Rsc Adv, 2015, 5(1):85-92.
[19] FAN Y, MAN S, LI H, et al. Analysis of bioactive components and pharmacokinetic study of herb-herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill[J]. J Pharm Biomed, 2016, 120: 364-373.
[20] LIU Y, WEI W F, HUO J H, et al. Serum pharmacochemistry of Qinbai Qingfei concentrated pellets based on UPLC-Q-TOF-MS[J]. China J Chin Mater Med(中国中药杂志), 2017, 42(3):572-579.
[21] XIANG W Y, YANG W, MEI C Y, et al. Serum pharmacochemistry study on Huafengdan[J]. J China Pharm(中国药房), 2016, 27(28):3911-3914.
[22] MA H, LIU Y, MAI X, et al. Identification of the constituents and metabolites in rat plasma after oral administration of Huanglian Shangqing pills by ultra high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. J Pharm Biomed Anal, 2016, 125: 194-204.
[23] ZHU H, BI K, HAN F, et al. Identification of the absorbed components and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma by ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry[J]. J Pharm Biomed, 2015, 111: 277-287.
[24] XU W, WU X, HUANG M Q, et al. Analysis on pharmacodynamic constituents in Gualou Guizhi Decoction by serum pharmacochemistry[J]. Chin Tradit Herb Drugs(中草药), 2017, 48(10):2033-2043.
[25] SUN H, SUN W, ZHANG A, et al. Chapter 5:Analytical Characterization of Yin-Chen-Hao-Tang by Serum Pharmacochemistry of TCM, Serum Pharmacochemistry of Traditional Chinese Medicine[M]. London:Mica Haley, 2017.
[26] PAN T, OU Y B, XIAO Z Q, et al. Identification and assay of constituents of Chankangle Granules migrating to blood by HPLC-DAD[J]. Chin Hosp Pharm J(中国医院药学杂志), 2016, 36(11):908-911.
[27] ZHU T M, DUAN X Y, JIANG N, et al. Serum pharmacochemistry of compound Kudai decoction[J]. Cent South Pharm(中南药学), 2016, 14(9):944-947.
[28] WU J M, ZHANG Z R, ZHANG H C, et al. Study on serum pharmacochemistry of Keluoxin capsule[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2014, 16(8):1784-1788.
[29] MU J, GAO X, LI Q, et al. Vortex-ultrasound-assisted dispersive liquid-liquid microextraction coupled with gas chromatography-mass spectrometry for the analysis of volatile bioactive components and comparative pharmacokinetic study of the herb-herb interactions in Guanxin Shutong Capsule[J]. J Sep Sci, 2017, 40(16):3267-3278.
[30] CHEN Z, PAN M J, XING X F, et al. Research progress on serum pharmacochemistry studies in pharmacodynamics material basis of Chinese materia medica and Chinese herbal formula[J]. Drug Eval Res, 2016, 39(1):143-147.
[31] HOPKINS A L. Network pharmacology: the next paradigm in drug discovery[J]. Nat Chem Biol, 2008, 4(11):682-690.
[32] SONG K K, BI T, ZHAN X R, et al. Strategies for the discovery of active ingredients in traditional Chinese medicine under the guidance of network pharmacology[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2014, 16(1):27-31.
[33] PANG H Q, YUE S J, TANG Y P, et al. Integrated metabolomics and network pharmacology approach to explain possible action mechanisms of Xin-Sheng-Hua Granule for treating anemia[J]. Front Pharmacol, 2018, 9: 165.
[34] CHEN L, CAO Y, ZHANG H, et al. Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure[J]. J Ethnopharmacol, 2018, 219: 359-368.
[35] GAO L, WANG K X, ZHOU Y Z, et al. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation[J]. Sci Rep, 2018, 8(1):624.
[36] WANG Y, ZHAO Y, JIANG W, et al. iTRAQ-Based proteomic analysis reveals recovery of impaired mitochondrial function in ischemic myocardium by Shenmai Formula[J]. J Proteome Res, 2018, 17(2):794-803.
[37] LIU X, SHEN J, FAN D, et al. Yupingfeng San inhibits NLRP3 inflammasome to attenuate the inflammatory response in asthma mice[J]. Front Pharmacol, 2017, 8: 944.
[38] ZENG L, YANG K, GE J. Uncovering the pharmacological mechanism of astragalus salvia compound on pregnancy-induced hypertension syndrome by a network pharmacology approach[J]. Sci Rep, 2017, 7(1):16849.
[39] WU J R, JIN Y P, WANG K H, et al. Mechanism of lonicerae japonicae flos-weeping forsythia herbal pair based on network pharmacology[J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2017, 23(5):179-183.
[40] DENG X, XING X, SUN G, et al. Guanxin Danshen Formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor beta[J]. Front Pharmacol, 2017, 8: 777.
[41] HONG M, LI S, TAN H Y, et al. A network-based pharmacology study of the herb-induced liver injury potential of traditional hepatoprotective Chinese herbal medicines[J]. Molecules, 2017, 22(4):632.
[42] FANG H Y, ZENG H W, LIN L M, et al. A network-based method for mechanistic investigation of Shexiang Baoxin Pill′s treatment of cardiovascular diseases[J]. Sci Rep, 2017, 7: 43632.
[43] ZENG L, YANG K. Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach[J]. J Ethnopharmacol, 2017, 199(5):68-85.
[44] WANG N, ZHENG Y, GU J, et al. Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis[J]. Sci Rep, 2017, 7(1):14513.
[45] BROACH J R, THORNER J. High-throughput screening for drug discovery[J]. Nature, 1996, 384(6604 suppl):14-16.
[46] ZHANG D S. The application of them uniform design-high throughput on screening antioxidant research of 17 components Radix Salviae Miltiorrhizae and compound Danshen Tablets[J]. Acta Neuropharmacologica(神经药理学报), 2012, 2(6):1-17.
[47] LI R, YAN Z Y, LI W J, et al. To establish the relationship between Chinese traditional medicine (TCM)[J]. Educ Tradit Chin Med(中医教育), 2002, 21(2):62.
[48] CAI L, ZHANG Q, YANG F Q. Applications progress on spectrum-effect relationship in study of Chinese materia medica[J]. Chin Tradit Herb Drugs(中草药), 2017, 48(23):5005-5011.
[49] XIE R F, ZHOU X, SHI Z N, et al. Study on spectrum-effect relationship of rhizoma Rhei, cortex Magnoliae Officinalis, fructus Aurantii Immaturus and their formula[J]. J Chromatogr Sci, 2013, 51(6):524-532.
[50] WANG Y, LI Y, ZHANG Y, et al. Multi-dimensional spectrum-effect relationship of the impact of Chinese herbal formula Lichong Shengsui Yin on ovarian cancer[J]. Molecules, 2017, 22(6):979.
[51] DOU Z H, LUO L, HOU J Y, et al. Hepatoprotective ingredients of Yinchenhao Decoction based on the time-spectrum-effect relationship of serum containing drugs[J]. Chin J Hosp Pharm(中国医院药学杂志), 2017, 37(13):1232-1237.
[52] CHENG L, ZHENG J, XU P H, et al. Spectrum-effect relationship of anti-hepatic fibrosis effect of Liuwei Wuling Tablets[J]. Chin Tradit Pat Med(中成药), 2016, 38(4):820-825.
[53] ZHAO X L, LING J J, WEI J B. HPLC Fingerprint analysis of the extract from different batches of Sini decoction and relation of fingerprint with pharmacodynamics in anti myocardial ischemic effects[J]. Northern Pharm(北方药学), 2015, 12(12):98-100.
[54] YAN H Y, ZOU C C, WEI M L, et al. Spectrum-effect relationship of Gualou Xiebai Dropping Pills on myocardial ischemia[J]. J Chin Med Mater(中药材), 2015, 38(9):1912-1918.
[55] LIU T, WANG H D, DI L Q, et al. HPLC Specific chromatogram spectrum-effect relationship for Shuanghuanglian on MDCK cell injury induced by influenza A virus (H1N1)[J]. China J Chin Mater Med(中国中药杂志), 2015, 40(21):4194-4199.
[56] ZHANG F, ZHAN Q, DONG X, et al. Shengxian decoction in chronic heart failure treatment and synergistic property of Platycodonis Radix: a metabolomic approach and its application[J]. Mol Biosyst, 2014, 10(8):2055-2063.
[57] ZHOU Y Z, WANG Y, RONG J F, et al. Application of metabolomics in TCM syndrome differentiation of coronary heart disease[J]. Chin J Integr Med Cardio-/Cerebrovasc Dis(中西医结合心脑血管病杂志), 2016, 14(15):1738-1741.
[58] MA F X, XUE P F, WANG Y Y, et al. Research progress of serum pharmacochemistry of traditional Chinese medicine [J]. China J Chin Mater Med(中国中药杂志), 2017, 42(7):1265-1270.
[59] XIN X, ZOU H, ZHENG N, et al. Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats[J]. Evid Based Complement Alternat Med, 2013, 2013(3):718305.
[60] LIU P, WANG P. Application of metabolomics technology in the research of Chinese medicine[J]. Chin J Integr Med(中国中西医结合杂志 英文版), 2014, 20(4):307-310.
[61] WANG N, ZHAO X, HUAI J, et al. Arachidonic acid metabonomics study for understanding therapeutic mechanism of Huo Luo Xiao Ling Dan on rat model of rheumatoid arthritis[J]. J Ethnopharmacol, 2018, 217: 205-211.
[62] WEI Z, XU C, LIU S, et al. Metabonomics study of the effects of traditional Chinese medicine formula Ermiaowan on hyperuricemic rats[J]. J Sep Sci, 2018, 41(2):560-570.
[63] MU F, DUAN J, BIAN H, et al. Metabonomic strategy for the evaluation of Chinese medicine salvia miltiorrhiza and dalbergia odorifera interfering with myocardial ischemia/reperfusion injury in rats[J]. Rejuven Res, 2017, 20(4):263-277.
[64] SHUI S, CAI X, HUANG R, et al. Metabonomic analysis of serum reveals antifatigue effects of Yi Guan Jian on fatigue mice using gas chromatography coupled to mass spectrometry[J]. Biomed Chromatogr, 2018, 32(2):e4085.
[65] GUO Y, LI Z, LIU X, et al. ¹H-NMR-Based metabonomic study of functional dyspepsia in stressed rats treated with Chinese medicine Weikangning[J]. Evid Based Compl Alter Med, 2017, 2017(3):1-18.
[66] JIANG M, WANG Q, CHEN J, et al. Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid beta-oxidation in myocardial injury protection[J]. Sci Rep, 2017, 7(1):8739.
[67] LI P, LIAO S T, WANG J S, et al. Protection by Huang-Lian-Jie-Du decoction and its constituent herbs of lipopolysaccharide-induced acute kidney injury[J]. Febs Open Bio, 2017, 7(2):221-236.
[68] SHUI S, CAI X, HUANG R, et al. The investigation of anti-inflammatory activity of Yi Guanjian decoction by serum metabonomics approach[J]. J Pharm Biomed Anal, 2017, 133(10):41-48.
[69] TANG F, LIANG S Y, TIAN Y X, et al. Predicting effective components and targets of essential oil of Asari Radix et Rhizoma on allergic rhinitis[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2015, 21(24):126-131.
[70] ZHOU X, ZHANG A, WANG L, et al. Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome[J]. Chin J Nat Med, 2016, 14(8):561-581.
[71] ZHOU W B, LIN L, LI Z Y, et al. Study on active ingredient and mechanism in preventing vascular dementia of Tianzhusan coming from Tujia medicine[J]. China J Chin Mater Med(中国中药杂志), 2015, 40(13):2668-2673.
[72] XIANG Z, SUN H, CAI X, et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Mol Biosyst, 2015, 11(4):1067-1078.
[73] GAO K, YANG R, ZHANG J, et al. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology[J]. Pharmacol Res, 2018, 130: 93-109.
[74] ZHANG Z, LU F, LIU H, et al. An integrated strategy by using target tissue metabolomics biomarkers as pharmacodynamic surrogate indices to screen antipyretic components of Qingkaikling injection[J]. Sci Rep, 2017, 7(1):6310.
[75] XIANG Z, SUN H, CAI X, et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Mol Biosyst, 2015, 11(4):1067-1078.
[76] GUO Q, TIAN C W, REN T, et al. Progress in basic research on the pharmacodynamic substances of traditional Chinese medicine[J]. World Sci Technol Mod Tradit Chin Med Mater Med(世界科学技术-中医药现代化), 2015, 17(3):648-654.